Medical Director, US Medical Affairs

Dyne Therapeutics•Waltham, MA

3d•Onsite

About The Position

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook. The US Medical Director of Medical Affairs leads Dyne’s medical strategy and execution within the United States, focusing on launch readiness, US-specific KOL engagement, congress planning and execution, and supports real-world evidence (RWE) initiatives. This role ensures alignment with global strategy while tailoring activities to US regulatory, payer, and healthcare landscapes. This role leads efforts to communicate and disseminate scientific and clinical information, engage with medical professionals in the field and contribute to the overall success of the company’s portfolio. The US Medical Director collaborates closely with Global Medical Affairs, US Commercial, Regulatory, Market Access, and Clinical teams to drive successful product introduction and lifecycle management in the US market. This role is located in our Waltham, MA office.

Requirements

Doctorate degree (MD, PhD, PharmD) with experience in rare diseases; neuromuscular experience preferred
Minimum 8 years of relevant experience in Medical Affairs within the US pharmaceutical/biotech industry
Proven ability to lead US launch readiness and medical strategy execution
Excellent communication and relationship-building skills with US KOLs and cross-functional teams
Ability to interpret and communicate complex scientific data to diverse audiences
Effective communication skills (written, verbal and presentation)
Must be willing to travel up to 30%, inclusive of overnight and occasional weekends to meet with customers, internal stakeholders and attend relevant conferences
Candidates must be authorized to work in the U.S.
Positive team member who embodies Dyne’s Core Values
Excitement about Dyne’s vision and mission
Experience managing direct reports

Responsibilities

Develop and execute US Medical Affairs strategy aligned with global objectives and US market needs
Act as point person for all US Medical Affairs launch readiness activities, including working closely with global medical director and scientific communications on development of scientific platform development, local congress planning, and local medical education programs
Support congress strategy execution in the US, including booth activities, symposia, and scientific presentations
Work closely and with the Head of the Medical Science Liaison (MSL) team on US KOL engagement strategy: identify, map, and build relationships with key US experts
Support insight collection and synthesis, and supporting the development of field material, working with the MSL team
Develop US Medical Affairs advisory board strategy and organize and execute advisory boards and expert panels
Work collaboratively with HCP and Patient Marketing as well as cross-functional stakeholders to integrate medical perspectives into brand strategy, ensuring alignment with scientific and commercial objectives
Partner with Clinical Development and Clinical Operations to support US trial site engagement and recruitment strategies
Working with the Global Medical Director, identify opportunities to generate real-world evidence (RWE) and phase IV data to address data gaps and support HCP and payer treatment decisions
Ensure compliance with US regulatory and legal requirements for all medical activities
Serve as subject matter expert on neuromuscular diseases and Dyne’s therapeutic platforms for US stakeholders
Support the review and approval of externally presented materials through the Medical Review committee and Promotional Review Committee
Act as a role model for integrity and compliance in all interactions